Clinical Trial

Povidone Iodine Efficacy Study

Study acronym: PIES
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S-ECC). At baseline, following oral rehabilitation in the operating room {10% (PVPI + Fluoride Varnish (FV)} will be compared to the current standard of care (Placebo + FV). Study participants will be followed for approximately 24 months post-baseline. The study interventions post-baseline will be administered at 3, 6, 9, 12, 15, 18, and 21 months.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2022-02-28; most recent amendment 2026-02-24.
Status change: Not Yet Recruiting → Recruiting 2022-09-06
Trial Details
NCT Number NCT05272254
Lead Sponsor University of Rochester
Conditions Early Childhood Caries
Enrollment 202 participants
Start Date 2022-09-15
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-27